Stryker Corporation provides reprocessing services (reverse-engineer OEM (original equipment manufacturer) devices, validate cleanliness and sterility, validate functional performance, validate replacement components as equivalent to new) and reprocessed medical devices, which are used in the operating room, the electrophysiology laboratory, and on the general floor of hospitals & other healthcare facilities. The company has a leading position in the medical device reprocessing market, owing to its diversified product portfolio and well-established service offerings. The company is focused on R&D activities to provide quality reprocessing services and reprocessed medical devices. The overall R&D expenditure of the company is USD 715 million, USD 625 million, and USD 614 million in 2016, 2015, and 2014, respectively. Source: MarketsandMarkets Analysis